BridgeBio Pharma, Inc. (BBIO) Earnings Per Share (EPS)
BridgeBio Pharma, Inc. (BBIO) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2019-12-31 | -$2.48 |
| 2020-12-31 | -$3.80 |
| 2021-12-31 | -$3.90 |
| 2022-12-31 | -$3.26 |
| 2023-12-31 | -$3.95 |
| 2024-12-31 | -$2.88 |
| 2025-12-31 | -$3.78 |
How BBIO compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| REPL | Replimune Group Inc. | -$3.38 |
| VNDA | Vanda Pharmaceuticals Inc. | -$3.74 |
| CELC | Celcuity Inc. | -$3.79 |
| NTLA | Intellia Therapeutics Inc. | -$3.81 |
| ATOS | Atossa Therapeutics Inc. | -$4.04 |
These are five companies in the same sector as BBIO with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get BridgeBio Pharma, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("BBIO")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BBIO | $79.86 | -1.66% | 3.09M |
| 3 | ||||
| 4 | ||||
| 5 |